Variant focal segmental collapsing glomerulosclerosis associated with COVID-19 vaccine and highrisk APOL1 genotype clinical case report and bibliographic review
- Urology & Nephrology Open Access Journal
-
Tânia Claudina Suin Chin,1 Maria Izabel Neves de Holanda Barbosa,2 Mauricio Younes Ibrahim,2 Jessica Viviana Velecela Chumbi,2 Sebastiam Alejandro Izquierdo Coronel2
PDF Full Text
Abstract
Introduction: The COVID-19 pandemic, produced by a mutant strain of coronavirus SARS-CoV-2, which caused worldwide chaos never seen before, started in China in December 2019. In Brazil the first case was confirmed on February 26, 2020 with a 61- year -old patient and the World Health Organization declared a pandemic on March 11, 2020; the aggressiveness of the disease led to an accelerated search for treatments and vaccines, just in July 2021, there were 184 vaccine candidates against COVID-19; Along with immunization, several adverse effects generated by the various vaccines have been reported, ranging from mild to severe, from minor pain at the puncture site to headache, fever, arthralgias, etc. Severe cases have also been reported, such as anaphylaxis, heart disease, renal alterations, etc. which to date are not fully determined.
Keywords
COVID-19, pfizer-biontech, moderna, Oxford/ Astra Zeneca vaccines